Investor Relations

Corporate Overview

PDS Biotech is a clinical stage biopharmaceutical company with a growing pipeline of cancer immunotherapies and infectious disease vaccines. Our team is committed to developing first-in-class T cell activating immunotherapies to fight against cancer and to provide more rapid and longer-lasting protection against infectious diseases.


noun cells 3844187

3 Proprietary T cell activating platforms
noun pharmacogenomics 4478854

4 Ongoing Phase 2 clinical trials
noun partnership 3317408

With Merck, MD Anderson Cancer Center,
National Cancer Institute and Mayo Clinic

Corporate Presentation



This website use cookies to facilitate the use of the website, improve its performance and security, personalize the proposed content.